AGGA yields 3.62% · MRK yields 2.76%● Live data
📍 MRK pulled ahead of the other in Year 1
Combined, AGGA + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of AGGA + MRK for your $10,000?
AGGA uses third party ETFs to actively manage core fixed income exposure, based on macroeconomic analysis. Investments may include US Treasuries, corporate bonds, mortgage-backed securities, municipal bonds, and high-yield bonds of any duration. To a lesser extent, the fund may also hold ETFs with non-US fixed income exposure, including emerging markets. The funds advisers utilize proprietary processes influenced by market conditions, interest rates, and credit risks to adjust the portfolio in attempt to outperform broad-based benchmarks. Considering both actively managed and passively managed ETFs, the fund typically holds 5-15 underlying ETFs. Allocations are adjusted when deemed necessary and rebalancing at least monthly. The fund is non-diversified, which means it may concentrate assets in fewer securities.
Full AGGA Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.